| Literature DB >> 34123984 |
Sultana A Alhurishi1, Khalid M Almutairi1, Jason M Vinluan1, Ahmad E Aboshaiqah2, Mohammed A Marie3.
Abstract
Objective: In this descriptive cross-sectional study we aimed, to assess the level of depression, anxiety, insomnia and distress symptoms experienced by healthcare providers during the COVID-19 pandemic in Saudi Arabia.Entities:
Keywords: COVID-19; Saudi Arabia; healthcare providers; mental health; pandemic
Mesh:
Year: 2021 PMID: 34123984 PMCID: PMC8193120 DOI: 10.3389/fpubh.2021.625523
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Demographic characteristic of the participants.
| Mean 33.2 SD 6.4 | ||
| 21–30 years | 74 | 37 |
| 31–40 years | 104 | 52 |
| 41 and above | 22 | 11 |
| Male | 80 | 40 |
| Female | 120 | 60 |
| Saudi | 169 | 84 |
| Non-Saudi | 31 | 16 |
| Single | 77 | 39 |
| Married | 123 | 61 |
| Diploma | 26 | 13 |
| Bachelor | 104 | 52 |
| Post graduate | 70 | 35 |
| Private | 16 | 8 |
| Government | 184 | 92 |
| Primary | 52 | 26 |
| Secondary | 36 | 18 |
| Tertiary | 49 | 24 |
| Specialize medical center | 38 | 19 |
| Other | 25 | 13 |
| Nurse | 147 | 74 |
| Physician | 23 | 11 |
| Others | 30 | 15 |
| Frontline | 115 | 58 |
| Second-line | 85 | 42 |
| Riyadh | 82 | 41 |
| Jeddah | 18 | 9 |
| Dammam | 7 | 4 |
| Madinah | 12 | 6 |
| Other | 81 | 40 |
| Mean 9.3 SD 6.1 | ||
| 5 years and below | 70 | 35 |
| 6–10 years | 49 | 25 |
| 11–15 years | 81 | 40 |
| Mean 5.8 SD 5.1 | ||
| 5 years and below | 123 | 61 |
| 6–10 years | 43 | 22 |
| 11–15 years | 34 | 17 |
Level of depression, anxiety, insomnia and distress among healthcare providers in total cohort and subgroups.
| 9 (4–13) | |||||||||||
| None-minimal (0–4) | 53 (26.5) | 38 (25.9) | 5 (21.7) | 10 (33.3) | 20 (25) | 33 (27.5) | 24 (20.9) | 29 (34.1) | 0.250 | ||
| Mild (5–9) | 52 (26) | 38 (25.9) | 7 (30.4) | 7 (23.3) | 20 (25) | 32 (26.7) | 33 (28.7) | 19 (22.4) | |||
| Moderate (10–14) | 57 (28.5) | 42 (28.6) | 3 (13) | 12 (40) | 28 (35) | 29 (24.2) | 37 (32.2) | 20 (23.5) | |||
| Severe (15–21) | 38 (19) | 29 (19.7) | 8 (34.7) | 1 (3.3) | 12 (15) | 26 (21.7) | 21 (18.3) | 17 (20) | |||
| 10 (3–13) | |||||||||||
| Normal | 62 (31) | 50 (34) | 3 (13) | 9 (30) | 0.209 | 23 (28.7) | 39 (32.5) | 31 (27) | 31 (36.5) | 0.182 | |
| Mild | 71 (35.5) | 47 (32) | 10 (43.5) | 14 (46.7) | 30 (37.5) | 41 (34.2) | 43 (37.4) | 28 (32.9) | |||
| Moderate | 37 (18.5) | 30 (20.4) | 4 (17.4) | 3 (10) | 18 (22.5) | 19 (15.8) | 26 (22.6) | 11 (12.9) | |||
| Severe | 30 (15) | 20 (13.6) | 6 (26.1) | 4 (13) | 9 (11.3) | 21 (17.5) | 15 (13) | 15 (17.6) | |||
| 8 (5–13) | |||||||||||
| Absence | 75 (37.5) | 53 (36.1) | 6 (26.1) | 16 (53.3) | 0.240 | 26 (32.5) | 49 (40.8) | 0.211 | 40 (34.8) | 35 (41.2) | 0.626 |
| Subthreshold | 86 (43) | 67 (45.6) | 9 (39.1) | 10 (33.3) | 36 (45) | 50 (41.7) | 52 (45.2) | 34 (40) | |||
| Moderate | 36 (18) | 25 (17) | 7 (30.4) | 4 (13.3) | 18 (22.5) | 18 (15) | 22 (19.1) | 14 (16.5) | |||
| Severe | 3 (1.5) | 2 (1.4) | 1 (4.3) | 0 | 0 | 3 (2.5) | 1 (0.9) | 2 (2.4) | |||
| 31 (13–44) | |||||||||||
| Normal | 34 (17) | 23 (15.6) | 3 (13) | 8 (26.7) | 14 (17.5) | 20 (16.7) | 0.558 | 19 (16.5) | 15 (17.6) | 0.712 | |
| Mild | 70 (35) | 53 (36.1) | 6 (26.1) | 11 (36.7) | 25 (31.3) | 45 (37.5) | 38 (33.0) | 32 (37.6) | |||
| Moderate | 43 (21.5) | 30 (20.4) | 6 (26.1) | 7 (23.3) | 21 (26.3) | 22 (18.3) | 28 (24.3) | 15 (17.6) | |||
| Severe | 53 (26.5) | 41 (27.9) | 8 (34.8) | 4 (13.3) | 20 (25) | 33 (27.5) | 30 (26.1) | 23 (27.1) | |||
GAD-7, 7-item generalized anxiety disorder; IES-R, 22-item impact of event scale–revised; ISI, 7-item insomnia severity index; PHQ-9, 9-item patient health questionnaire. P-value significant at P < 0.05. Bold values are considered significant (P-value significant at P < 0.05).
Predictors associated for mental health outcomes identified by multivariable logistic regression analysis.
| 0.645 | 0.450 | 0.732 | 0.523 | |||||
| 21–30 years | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| 31–40 years | 1.11 (0.33–3.70) | 0.93 (0.37–2.36) | 1.57 (0.50–4.90) | 1.05 (0.35–3.10) | ||||
| 41 and above | 2.74 (0.30–24.72) | 2.67 (0.43–16.53) | 1.57 (0.17–14.53) | 0.36 (0.05–2.69) | ||||
| 0.566 | 0.470 | |||||||
| Male | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| Female | 1.94 (0.89–4.22) | 1.42 (0.34–5.94) | 0.79 (0.38–1.63) | 1.27(0.65–2.46) | ||||
| 0.077 | 0.891 | 0.161 | 0.119 | |||||
| Saudi | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1[Reference] | ||||
| Non–Saudi | 3.07 (0.88–10.65) | 1.07 (0.38–2.96) | 2.31 (0.71–7.52) | 2.32 (0.80–6.75) | ||||
| 0.842 | 0.597 | 0.291 | 0.225 | |||||
| Single | 1[Reference] | 1 [Reference] | 1[Reference] | 1 [Reference] | ||||
| Married | 0.90 (0.33–2.46) | 0.81 (0.37–1.76) | 0.59 (0.22–1.55) | 0.58 (0.24–1.38) | ||||
| 0.061 | 0.064 | 0.681 | 0.051 | |||||
| Diploma | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| Bachelor | 0.31 (0.09–1.05) | 0.98 (0.35–2.71) | 0.78 (0.21–2.90) | 0.50 (0.16–1.54) | ||||
| Post graduate | 0.08 (0.01–0.50) | 0.33 (0.09–1.15) | 0.52 (0.11–2.49) | 0.17 (0.04–0.72) | ||||
| 0.199 | 0.339 | 0.390 | 0.366 | |||||
| Private | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| Government | 0.38 (0.08–1.67) | 1.33 (0.47–3.76) | 1.62 (0.53–4.93) | 0.56 (0.16–1.94) | ||||
| Nurse | 1[Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| Physician | 2.43 (0.91–6.47) | 0.57 (0.32–1.30) | 2.32 (0.89–6.07) | 1.44 (0.56–3.68) | ||||
| Others | 0.10 (0.13–0.81) | 0.72 (0.05–9.31) | 0.69 (0.13–2.26) | 0.34 (0.10–1.08) | ||||
| 0.372 | 0.884 | |||||||
| Frontline | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| Second–line | 0.48 (0.09–2.37) | 1.56 (0.73–3.31) | 1.05 (0.50–2.22) | 0.92 (0.44–1.92) | ||||
| 0.531 | 0.618 | 0.980 | 0.537 | |||||
| Riyadh | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| Other | 1.43 (0.46–4.42) | 0.76 (0.26–2.18) | 1.01 (0.33–3.04) | 0.49 (0.05–4.65) | ||||
| 0.093 | 0.272 | 0.929 | 0.168 | |||||
| 5 years and below | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| 6–10 years | 1.63 (0.42–6.23) | 0.50 (0.17–1.48) | 0.76 (0.20–2.87) | 0.30 (0.08–1.10) | ||||
| 11–15 years | 0.62 (0.13–2.94) | 0.82 (0.26–2.60) | 1.12 (0.30–4.24) | 1.06 (0.30–3.72) | ||||
| 0.388 | 0.961 | 0.484 | 0.215 | |||||
| 5 years and below | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | ||||
| 6–10 years | 0.54 (0.14–2.01) | 1.11 (0.39–3.10) | 0.51 (0.63–0.16) | 0.32 (0.08–1.28) | ||||
| 11 and above | 1.61 (0.30–8.57) | 1.32 (0.38–4.51) | 2.39 (0.58–9.84) | 0.99 (0.25–3.85) | ||||
GAD-7, 7-item generalized anxiety disorder; IES-R, 22-item impact of event scale–revised; ISI, 7-item insomnia severity index; PHQ-9, 9-item patient health questionnaire. P-value significant at P < 0.05. Bold values are considered significant (P-value significant at P < 0.05).